#USA #Atlanta #Medical Devices #ClariMed #We Are Human

ClariMed Inc. Acquires We Are Human: A Strategic Move Towards Growth

In a significant industry transition, ClariMed Inc. has announced the acquisition of We Are Human, a consultancy firm with a strong emphasis on user-focused design and research in medical technology. This strategic move is set to broaden ClariMed’s operational footprint into the Southeast, leveraging We Are Human's advanced usability lab located in Atlanta, Georgia.

Founded in 2020, We Are Human is acclaimed for its innovative approach to human-centered research and design, which is vital for the advancement of medical technologies tailored to user needs. With the addition of their expert team and cutting-edge research facilities, ClariMed reinforces its commitment to delivering superior human-centered medical technologies.

Expanding Regional Capabilities

The merger will enable ClariMed to provide more targeted services and address specific patient needs that vary regionally. Kelley Kendle, CEO of ClariMed, articulated that the acquisition not only amplifies the company’s capabilities but also strengthens its fundamental mission. The integration is expected to improve the user experience in medical devices, ensuring these technologies are safe, intuitive, and impactful for patients in need.

Moreover, the acquisition brings along ISO 13485 certification and proficiency in regulatory compliance, including familiarity with IEC-62366 and FDA Guidance requirements. This strengthens ClariMed’s position as a comprehensive service provider in the medical device landscape, allowing for a seamless alignment of regulatory standards and user experience research that is crucial for efficient medical device development.

Enhancing Healthcare Through Innovation

With the acquisition, We Are Human founder Annmarie Nicolson steps into the role of Principal at ClariMed, contributing her vast experience in early-stage formative research and user experience to the leadership team. This transition is aimed at amplifying the health sector's impact through a dedicated emphasis on user-centered research methodologies and product design.

“Joining ClariMed represents an exciting opportunity to amplify our impact in healthcare through human-centered research and design,” said Nicolson. The commitment shared by both organizations to prioritize user needs and lifestyles is seen as a pivotal factor in their collaboration.

A National and International Network

With this strategic acquisition, ClariMed establishes its first facility in the Southeast, adding to its growing network that currently includes offices in places like Chadds Ford (PA), Cambridge (MA), and various locations in the UK. Such geographical diversification not only enhances ClariMed's ability to serve its client base more effectively but also provides diverse talent pools for user research and usability testing.

The newly integrated Atlanta lab will allow ClariMed to engage diverse study populations, vital for developing user-centric medical technologies. As the medical device sector continues to evolve, this acquisition aligns with ClariMed's strategic goal of building holistic human-centered solutions that promise quicker market entry while heightening patient safety and experience.

About ClariMed and We Are Human

ClariMed is dedicated to the development and regulatory services of medical devices, focusing on cultivating human-centered innovations and ensuring the effective usage of medical products. Their comprehensive offerings integrate crucial human factors into all stages of device development.

We Are Human, with its roots in providing essential human factors research and user experience design, shares a philosophy that envisions healthcare solutions driven by the needs of the users. This merger not only strengthens ClariMed's portfolio but also enhances the ongoing growth and advancement of user-focused design in the medical device landscape.

As the medical landscape continues to shift, this acquisition signals ClariMed's aggressive strategy to lead the market with innovative, human-centric approaches to medical technology, ensuring that both patients and healthcare providers benefit from the advancements.

For further details, please visit ClariMed.